Atara Biotherapeutics, Inc. (ATRA) vs Rallybio Corporation (RLYB)

Atara Biotherapeutics, Inc. and Rallybio Corporation are both Biotechnology companies. Atara Biotherapeutics, Inc. and Rallybio Corporation are of similar size ($85.6M and $84.0M). Atara Biotherapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 3.3×. Rallybio Corporation grew revenue faster over the last twelve months: 1.18% against −96.7%. Rallybio Corporation has the higher net margin (0.00% vs −269.4%) and the lower return on invested capital (−944.4% vs 0.00%). Across the 15 metrics below, Rallybio Corporation leads on 10 and Atara Biotherapeutics, Inc. on 5.

Valuation

Metric ATRA RLYB Biotechnology median
P/E n/m 3.35 10.26
P/S 19.54 104.84 9.18
P/B n/m 0.97 2.05
Price to free cash flow n/m 2.91 24.81
EV/EBITDA n/m 0.03 0.65
EV/Sales 17.94 (0.86) 8.98
Earnings yield (14.66%) 29.87% (34.89%)
Free cash flow yield (17.38%) 34.41% (24.52%)

Profitability

Metric ATRA RLYB Biotechnology median
Gross margin 91.38% 100.00% 65.16%
Operating margin (229.67%) 0.00% 0.00%
Net margin (269.42%) 0.00% 0.00%
Free cash flow margin (353.49%) 0.00% 0.00%
Return on equity 46.33% 34.52% (50.12%)
Return on assets (57.62%) 32.85% (45.60%)
Return on invested capital 0.00% (944.36%) 0.00%

Growth

Metric ATRA RLYB Biotechnology median
Revenue growth (TTM) (96.72%) 1.18% 6.26%
EPS growth (last fiscal year) 122.52% 85.06% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATRA RLYB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.98 28.87 4.89
Net debt to EBITDA (0.22) 1.63 1.01

Dividend

Metric ATRA RLYB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATRA RLYB Biotechnology median
Market cap 84.02m 85.61m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack